Issue 41, 2022

Correction: Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy

Abstract

Correction for ‘Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy’ by Wei Du et al., Nanoscale, 2020, 12, 3317–3329, https://doi.org/10.1039/C9NR09835F.

Associated articles

Article information

Article type
Correction
Submitted
29 Sep 2022
Accepted
29 Sep 2022
First published
13 Oct 2022
This article is Open Access
Creative Commons BY license

Nanoscale, 2022,14, 15543-15543

Correction: Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy

W. Du, C. Chen, P. Sun, S. Zhang, J. Zhang, X. Zhang, Y. Liu, R. Zhang, C. Yan, C. Fan, J. Wu and X. Jiang, Nanoscale, 2022, 14, 15543 DOI: 10.1039/D2NR90196J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements